Consistent with the above results, our data showed that the expression of CEACAM1 was higher in more advanced stages, especially in stage III/IV respect to stage II, indicating its promotional role in HNSCC metastasis. This evidence concerns the gene CEACAM1 and head and neck squamous cell carcinoma.